These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 34974436)

  • 1. Listener Detection of Objectively Validated Acoustic Features of Speech in Huntington's Disease.
    Chan JCS; Stout JC; Shirbin CA; Vogel AP
    J Huntingtons Dis; 2022; 11(1):71-79. PubMed ID: 34974436
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Speech acoustic markers of early stage and prodromal Huntington's disease: a marker of disease onset?
    Vogel AP; Shirbin C; Churchyard AJ; Stout JC
    Neuropsychologia; 2012 Dec; 50(14):3273-8. PubMed ID: 22982606
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictors of phenotypic progression and disease onset in premanifest and early-stage Huntington's disease in the TRACK-HD study: analysis of 36-month observational data.
    Tabrizi SJ; Scahill RI; Owen G; Durr A; Leavitt BR; Roos RA; Borowsky B; Landwehrmeyer B; Frost C; Johnson H; Craufurd D; Reilmann R; Stout JC; Langbehn DR;
    Lancet Neurol; 2013 Jul; 12(7):637-49. PubMed ID: 23664844
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Speech in prodromal and symptomatic Huntington's disease as a model of measuring onset and progression in dominantly inherited neurodegenerative diseases.
    Chan JCS; Stout JC; Vogel AP
    Neurosci Biobehav Rev; 2019 Dec; 107():450-460. PubMed ID: 31419452
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biological and clinical characteristics of gene carriers far from predicted onset in the Huntington's disease Young Adult Study (HD-YAS): a cross-sectional analysis.
    Scahill RI; Zeun P; Osborne-Crowley K; Johnson EB; Gregory S; Parker C; Lowe J; Nair A; O'Callaghan C; Langley C; Papoutsi M; McColgan P; Estevez-Fraga C; Fayer K; Wellington H; Rodrigues FB; Byrne LM; Heselgrave A; Hyare H; Sampaio C; Zetterberg H; Zhang H; Wild EJ; Rees G; Robbins TW; Sahakian BJ; Langbehn D; Tabrizi SJ
    Lancet Neurol; 2020 Jun; 19(6):502-512. PubMed ID: 32470422
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Speech biomarkers in Huntington's disease: A cross-sectional study in pre-symptomatic, prodromal and early manifest stages.
    Kouba T; Frank W; Tykalova T; Mühlbäck A; Klempíř J; Lindenberg KS; Landwehrmeyer GB; Rusz J
    Eur J Neurol; 2023 May; 30(5):1262-1271. PubMed ID: 36732902
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Repeatable Battery for the Assessment of Neuropsychological Status, While Useful for Measuring Cognitive Changes in Manifest Huntington Disease, May Show Limited Utility in Premanifest Disease.
    Mustafa AI; Corey-Bloom J; Beltran-Najera I; Snell C; Castleton J; Smith H; Gilbert PE
    Cogn Behav Neurol; 2022 Sep; 35(3):198-203. PubMed ID: 35830248
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Visual Working Memory Impairment in Premanifest Gene-Carriers and Early Huntington's Disease.
    Dumas EM; Say MJ; Jones R; Labuschagne I; O'Regan AM; Hart EP; van den Bogaard SJ; Queller S; Justo D; Coleman A; Dar Santos RC; Dürr A; Leavitt BR; Tabrizi SJ; Roos RA; Stout JC
    J Huntingtons Dis; 2012; 1(1):97-106. PubMed ID: 25063192
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Language-Independent Acoustic Biomarkers for Quantifying Speech Impairment in Huntington's Disease.
    Fahed VS; Doheny EP; Collazo C; Krzysztofik J; Mann E; Morgan-Jones P; Mills L; Drew C; Rosser AE; Cousins R; Witkowski G; Cubo E; Busse M; Lowery MM
    Am J Speech Lang Pathol; 2024 May; 33(3):1390-1405. PubMed ID: 38530396
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuropsychiatric symptoms are very common in premanifest and early stage Huntington's Disease.
    Martinez-Horta S; Perez-Perez J; van Duijn E; Fernandez-Bobadilla R; Carceller M; Pagonabarraga J; Pascual-Sedano B; Campolongo A; Ruiz-Idiago J; Sampedro F; Landwehrmeyer GB; ; Kulisevsky J
    Parkinsonism Relat Disord; 2016 Apr; 25():58-64. PubMed ID: 26898966
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Arithmetic Word-Problem Solving as Cognitive Marker of Progression in Pre-Manifest and Manifest Huntington's Disease.
    Horta-Barba A; Martinez-Horta S; Perez-Perez J; Sampedro F; de Lucia N; De Michele G; Salvatore E; Kehrer S; Priller J; Migliore S; Squitieri F; Castaldo A; Mariotti C; Mañanes V; Lopez-Sendon JL; Rodriguez N; Martinez-Descals A; Júlio F; Janurio C; Delussi M; de Tommaso M; Noguera S; Ruiz-Idiago J; Sitek EJ; Wallner R; Nuzzi A; Pagonabarraga J; Kulisevsky J;
    J Huntingtons Dis; 2021; 10(4):459-468. PubMed ID: 34602494
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of neurocognitive disorder in Huntington's disease using the Enroll-HD dataset.
    Sierra LA; Ullman CJ; Baselga-Garriga C; Pandeya SR; Frank SA; Laganiere S
    Front Neurol; 2023; 14():1198145. PubMed ID: 37521291
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of occipital lobe cortical thickness on cognitive task performance: An investigation in Huntington's Disease.
    Johnson EB; Rees EM; Labuschagne I; Durr A; Leavitt BR; Roos RA; Reilmann R; Johnson H; Hobbs NZ; Langbehn DR; Stout JC; Tabrizi SJ; Scahill RI;
    Neuropsychologia; 2015 Dec; 79(Pt A):138-46. PubMed ID: 26519555
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cortical thickness, stance control, and arithmetic skill: An exploratory study in premanifest Huntington disease.
    Nanetti L; Contarino VE; Castaldo A; Sarro L; Bachoud-Levi AC; Giavazzi M; Frittoli S; Ciammola A; Rizzo E; Gellera C; Bruzzone MG; Taroni F; Grisoli M; Mariotti C
    Parkinsonism Relat Disord; 2018 Jun; 51():17-23. PubMed ID: 29496355
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Longitudinal resting state fMRI analysis in healthy controls and premanifest Huntington's disease gene carriers: a three-year follow-up study.
    Odish OF; van den Berg-Huysmans AA; van den Bogaard SJ; Dumas EM; Hart EP; Rombouts SA; van der Grond J; Roos RA;
    Hum Brain Mapp; 2015 Jan; 36(1):110-9. PubMed ID: 25139578
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Two different phenomena in basic motor speech performance in premanifest Huntington disease.
    Skodda S; Grönheit W; Lukas C; Bellenberg B; von Hein SM; Hoffmann R; Saft C
    Neurology; 2016 Apr; 86(14):1329-1335. PubMed ID: 26962067
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Brain activation and functional connectivity in premanifest Huntington's disease during states of intrinsic and phasic alertness.
    Wolf RC; Grön G; Sambataro F; Vasic N; Wolf ND; Thomann PA; Saft C; Landwehrmeyer GB; Orth M
    Hum Brain Mapp; 2012 Sep; 33(9):2161-73. PubMed ID: 22887827
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microstructural brain abnormalities in Huntington's disease: A two-year follow-up.
    Odish OF; Leemans A; Reijntjes RH; van den Bogaard SJ; Dumas EM; Wolterbeek R; Tax CM; Kuijf HJ; Vincken KL; van der Grond J; Roos RA
    Hum Brain Mapp; 2015 Jun; 36(6):2061-74. PubMed ID: 25644819
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LASSI-L detects early cognitive changes in pre-motor manifest Huntington's disease: a replication and validation study.
    Sierra LA; Hughes SB; Ullman CJ; Hall A; Pandeya SR; Schubert R; Frank SA; Halko MA; Corey-Bloom J; Laganiere S
    Front Neurol; 2023; 14():1191718. PubMed ID: 37533473
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impaired postural stability as a marker of premanifest Huntington's disease.
    Salomonczyk D; Panzera R; Pirogovosky E; Goldstein J; Corey-Bloom J; Simmons R; Gilbert PE
    Mov Disord; 2010 Oct; 25(14):2428-33. PubMed ID: 20818666
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.